361 related articles for article (PubMed ID: 38786601)
1. Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes.
Giuliani ME; Bigossi G; Lai G; Marcozzi S; Brunetti D; Malavolta M
Mar Drugs; 2024 May; 22(5):. PubMed ID: 38786601
[TBL] [Abstract][Full Text] [Related]
2. Seaweeds as Nutraceutical Elements and Drugs for Diabetes Mellitus: Future Perspectives.
Cotas J; Lomartire S; Pereira L; Valado A; Marques JC; Gonçalves AMM
Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667785
[TBL] [Abstract][Full Text] [Related]
3. Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model.
Yang SC; Hsu CY; Chou WL; Fang JY; Chuang SY
Molecules; 2020 Dec; 25(23):. PubMed ID: 33287318
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in the Discovery and Development of Marine Natural Products with Cardiovascular Pharmacological Effects.
Zhou JB; Luo R; Zheng YL; Pang JY
Mini Rev Med Chem; 2018; 18(6):527-550. PubMed ID: 28969542
[TBL] [Abstract][Full Text] [Related]
5. Updates on Managing Type 2 Diabetes Mellitus with Natural Products: Towards Antidiabetic Drug Development.
Alam F; Islam MA; Kamal MA; Gan SH
Curr Med Chem; 2018; 25(39):5395-5431. PubMed ID: 27528060
[TBL] [Abstract][Full Text] [Related]
6. Biotechnological Innovations from Ocean: Transpiring Role of Marine Drugs in Management of Chronic Disorders.
Bhatia S; Makkar R; Behl T; Sehgal A; Singh S; Rachamalla M; Mani V; Iqbal MS; Bungau SG
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268639
[TBL] [Abstract][Full Text] [Related]
7. Marine Microalgal Products with Activities against Age-Related Cardiovascular Diseases.
Yurika N; Montuori E; Lauritano C
Mar Drugs; 2024 May; 22(5):. PubMed ID: 38786620
[TBL] [Abstract][Full Text] [Related]
8. Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects.
Rahman MM; Rahaman MS; Islam MR; Rahman F; Mithi FM; Alqahtani T; Almikhlafi MA; Alghamdi SQ; Alruwaili AS; Hossain MS; Ahmed M; Das R; Emran TB; Uddin MS
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011465
[TBL] [Abstract][Full Text] [Related]
9. SGLT2 Inhibitors and Cardiovascular Outcomes: Do they Differ or there is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL Study.
Kyriakos G; Quiles-Sanchez LV; Garmpi A; Farmaki P; Kyre K; Savvanis S; Antoniou VK; Memi E
Curr Cardiol Rev; 2020; 16(4):258-265. PubMed ID: 31362691
[TBL] [Abstract][Full Text] [Related]
10. Natural products with potential hypoglycemic activity in T2DM: 2019-2023.
Fei Z; Xu Y; Zhang G; Liu Y; Li H; Chen L
Phytochemistry; 2024 Jul; 223():114130. PubMed ID: 38714289
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes.
Paneni F; Lüscher TF
Am J Med; 2017 Jun; 130(6S):S18-S29. PubMed ID: 28526186
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus-Part 1.
Yandrapalli S; Jolly G; Horblitt A; Pemmasani G; Sanaani A; Aronow WS; Frishman WH
Cardiol Rev; 2020; 28(4):177-189. PubMed ID: 32282393
[TBL] [Abstract][Full Text] [Related]
13. Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade.
Kocyigit D; Gurses KM; Yalcin MU; Tokgozoglu L
Endocr Metab Immune Disord Drug Targets; 2017; 17(1):19-31. PubMed ID: 28440199
[TBL] [Abstract][Full Text] [Related]
14. Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study.
Fu AZ; Qiu Y; Radican L; Yin DD; Mavros P
Cardiovasc Diabetol; 2010 Apr; 9():15. PubMed ID: 20409333
[TBL] [Abstract][Full Text] [Related]
15. Lessons from the past and charting the future of marine natural products drug discovery and chemical biology.
Gerwick WH; Moore BS
Chem Biol; 2012 Jan; 19(1):85-98. PubMed ID: 22284357
[TBL] [Abstract][Full Text] [Related]
16. Marine Natural Products: A Source of Novel Anticancer Drugs.
Khalifa SAM; Elias N; Farag MA; Chen L; Saeed A; Hegazy MF; Moustafa MS; Abd El-Wahed A; Al-Mousawi SM; Musharraf SG; Chang FR; Iwasaki A; Suenaga K; Alajlani M; Göransson U; El-Seedi HR
Mar Drugs; 2019 Aug; 17(9):. PubMed ID: 31443597
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes.
Paneni F; Lüscher TF
Am J Cardiol; 2017 Jul; 120(1S):S17-S27. PubMed ID: 28606340
[TBL] [Abstract][Full Text] [Related]
18. Phytochemical, Anti-diabetic and Cardiovascular Properties of Urtica dioica L. (Urticaceae): A Review.
El Haouari M; Rosado JA
Mini Rev Med Chem; 2019; 19(1):63-71. PubMed ID: 30246639
[TBL] [Abstract][Full Text] [Related]
19. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
Schernthaner G; Schernthaner-Reiter MH; Schernthaner GH
Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
[TBL] [Abstract][Full Text] [Related]
20. A Molecular Modeling Investigation of the Therapeutic Potential of Marine Compounds as DPP-4 Inhibitors.
Antony P; Baby B; Aleissaee HM; Vijayan R
Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
